Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

28 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.94M shares of 92.2M outstanding shares and own 4.27% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (1.11M shares), Ally Bridge Group (NY) LLC (726K shares), VANGUARD GROUP INC (598K shares), Affinity Asset Advisors, LLC (329K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (297K shares), ADAR1 Capital Management, LLC (206K shares), HighTower Advisors, LLC (126K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (106K shares), Mill Creek Capital Advisors, LLC (105K shares), and GEODE CAPITAL MANAGEMENT, LLC (101K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.